The Value of Shingles Vaccination—May 2026

The Value of Shingles Vaccination—May 2026

Canadian Economic Analysis Health and Healthcare
Pages:27 pages21 min read

Author: Signal49 Research

$0.00

This report examines the direct and indirect value of a cohesive publicly funded adult vaccination program in Canada through a lens that tightly links workforce and non-labour participation, health system sustainability, and quality of life.

Want a discount? Become a member by purchasing a subscription! Learn More

Healthy Aging and Building Economic Resilience: The Value of Shingles Vaccination

In this research, we examine the direct and indirect value of a cohesive publicly funded adult vaccination program in Canada through a lens that tightly links workforce and non-labour participation, health system sustainability, and quality of life.

How does healthy aging for the population support Canada’s economy? How does having a national, coordinated shingles prevention program factor into this? What five actionable insights do we offer for decision-makers who are challenged with bolstering Canada’s economic resilience and addressing the wellbeing of an aging population?

Read the impact paper to get our full analysis.

Key findings
Productivity and healthy aging
Economic and social imperative of healthy aging
Shingles vaccination: Preventing burden on Canadians
Impacts on patients, healthcare systems, and society
Realizing value
Actionable insights
Appendix A: Methodology
Appendix B: Bibliography

Questions?

Call 1-888-801-8818 or send us a message (Mon–Fri: 8 am to 5 pm).

This field is hidden when viewing the form
This field is hidden when viewing the form

Require an accessible version of this research?

Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.

Learn more about our accessibility policies.

Reviews

Be the first to review “The Value of Shingles Vaccination—May 2026”

There are no reviews yet.